Although existing data on MVs in HNSCC are promising, a more detailed analysis of their molecular content may reveal novel biomarkers and help to elucidate mechanisms of tumor progression and therapeutic resistance, particularly during anti‐EGFR therapy. This evidence concerns the gene EGFR and neoplasm.